| Literature DB >> 30449685 |
Diane C Saunders1, Marcela Brissova2, Neil Phillips2, Shristi Shrestha3, John T Walker1, Radhika Aramandla2, Greg Poffenberger2, David K Flaherty4, Kevin P Weller4, Julie Pelletier5, Tracy Cooper6, Matt T Goff6, John Virostko7, Alena Shostak2, E Danielle Dean2, Dale L Greiner8, Leonard D Shultz9, Nripesh Prasad3, Shawn E Levy3, Robert H Carnahan10, Chunhua Dai2, Jean Sévigny11, Alvin C Powers12.
Abstract
Identification of cell-surface markers specific to human pancreatic β cells would allow in vivo analysis and imaging. Here we introduce a biomarker, ectonucleoside triphosphate diphosphohydrolase-3 (NTPDase3), that is expressed on the cell surface of essentially all adult human β cells, including those from individuals with type 1 or type 2 diabetes. NTPDase3 is expressed dynamically during postnatal human pancreas development, appearing first in acinar cells at birth, but several months later its expression declines in acinar cells while concurrently emerging in islet β cells. Given its specificity and membrane localization, we utilized an NTPDase3 antibody for purification of live human β cells as confirmed by transcriptional profiling, and, in addition, for in vivo imaging of transplanted human β cells. Thus, NTPDase3 is a cell-surface biomarker of adult human β cells, and the antibody directed to this protein should be a useful new reagent for β cell sorting, in vivo imaging, and targeting.Entities:
Keywords: development; diabetes; glucagon; imaging; insulin; islet; pancreas
Mesh:
Substances:
Year: 2018 PMID: 30449685 PMCID: PMC6402969 DOI: 10.1016/j.cmet.2018.10.007
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287